Das, B.K., 2022. Altered gut microbiota in hepatocellular carcinoma: Insights into the pathogenic mechanism and preclinical to clinical findings. APMIS. [Impact Factor: 3.428]
Das, B.K., K, Jayalakshmi, Gadad P.C., 2022. 1H-NMR-based serum metabolomic study to evaluate the effect of asarone and metformin on experimentally induced diabetic hepatocellular carcinoma in rats. Bull. National Res Centre. 46:164.
Das, B.K., Gadad P.C., 2021. Impact of diabetes on the increased risk of hepatic cancer: An updated review of biological aspects. Diabetes Epidemiol Manag. 4:100025
Das, B.K., Koti, B.C., Swamy, A.H.M.V., Gadad P.C., World Congress on Drug Discovery Development. J N Tata Auditorium, Indian Institute of Science, Bengaluru. Page no: 1, Nov, 2016
Kamaiah, J., Das, B.K., Gadad P.C., 24th Conference of National Magnetic Resonance Society. Department of Physics, IISER Mohali, Punjab, India. Page no: 66, Feb, 2018.
Kiba, A, Saha, D., Das, B.K., NMPB (Ministry of AYUSH) Govt. of India Sponsored National Conference. Nagaon, Assam, India. Page no: 93, Jan, 2022.
Das, B.K., 2014. An overview on Hirudotherapy/leech therapy. Indian Res. J. Pharm. Sci., 1:33-45
Das, B.K., 2015. A brief scenario of Dengue virus. Int. J. Curr. Res., 7: 12864-12873.
Singh, M.K., Das, B.K., Trivedi, R., 2016. In vivo evaluation of immunomodulatory potential of ferulic acid. Int. Res. J. Pharm., 7: 12-17
Singh, M.K., Das, B.K., Patidar, P., 2016. The effect of methanolic extract of Buchanania lanzan Spreng seeds on hematological indices. Indian J. Pharmacol., 48: 214-215. [Impact Factor: 2.83]
Das, B.K., Singh, M.K., Kulkarni, J.M., 2016. Potential gastroprotective medicinal plants: An overview. Int. Res. J. Pharm., 7: 8-14
Das, B.K., Kulkarni, J.M., 2016. The landscape of therapeutic cancer vaccine. Int. J. Pharm. Sci. Res.,7:514-519
Das, B.K., Koti, B.C., Gadad, P.C., 2016. Role of Lycopersicon esculentum in diethylnitrosamine-induced and phenobarbital-promoted hepatocellular carcinoma. Indian J. Health Sci., 9:147-52
Singh, M.K., Das, B.K., Choudhary, S., Gupta, D., Patil, U.K., 2018. Diabetes and hepatocellular carcinoma: A pathophysiological link and pharmacological management. Biomed. Pharmacother., 106: 991-1002. [Impact Factor: 7.41]
Das, B.K., Koti, B.C., Patil, S.B., Gadad, P.C., 2019. Effect of Lycopersicon esculentum (tomato) on membrane-bound ATPases against diethylnitrosamine (DEN) induced and phenobarbital (PB) promoted hepatocellular carcinoma (HCC) in rats. Asian J. Pharm. Pharmacol., 5: 565-571.
Krishna, R.J., Pandagale, A., Ronad, P.M., Honnalli, S.S., Das, B.K., Gadad, P.C., 2019. Synthesis and pharmacological evaluation of schiff bases of 7-amino-4-methyl coumarins as novel anti-inflammatory agents. Asian J. Pharm. Pharmacol., 5: 693-700.
Das, B.K., Swamy, A.H.M.V., Koti, B.C.,Gadad, P.C., 2019. Experimental evidence for use of Acorus calamus (asarone) for cancer chemoprevention. Heliyon. 5: e01585. [Impact Factor: 3.77]
Das, B.K., Choukimath S.M., Gadad, P.C., 2019. Asarone and metformin delays experimentally induced hepatocellular carcinoma in diabetic milieu. Life Sci., 230:10-8. [Impact Factor: 6.78]
Das, B.K., Gadad, P.C., 2020. Asarone and metformin modulates the oxidant-antioxidant imbalance on experimentally induced hepatocellular carcinoma during diabetic condition. Indian J. Pharm. Educ. Res., 54:1039-1045. [Impact Factor: 0.843]
Das, B.K., Knott, R.M., Gadad, P.C., 2021. Metformin and asarone inhibit HepG2 cell proliferation in a high glucose environment by regulating AMPK and Akt signaling pathway. Futur. J. Pharm. Sci., 7: 43.
Das, B.K., Saha, D, Gadad, P.C., 2021. In silico discovery of novel phytoconstituents of Diplazium esculentum Retz. against diabetes mellitus. Chemistry Africa. 4:1-12.